Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2007

01-01-2007

Rosmarinic Acid Induces Apoptosis of Activated T Cells from Rheumatoid Arthritis Patients via Mitochondrial Pathway

Authors: YUN-GYOUNG HUR, CHANG-HEE SUH, SUNGJOO KIM, JONGHWA WON

Published in: Journal of Clinical Immunology | Issue 1/2007

Login to get access

Abstract

T cells play an important role in the initiation and the progression of rheumatoid arthritis (RA) and depletion of potentially pathogenic T cells was suggested as an important therapeutic protocol. We determined if rosmarinic acid (RosA), known as a secondary metabolite from herbal plants, had apoptotic activity toward T cells from RA patients and further verified target T-cell subsets. CD3+CD25+ activated T-cell subsets from most of the RA patients displayed significantly higher apoptosis rates than did the PBMCs and total CD3+ T cells. Furthermore, activated and effector CD4+ T cells, including CD4+CD25+ and CD4+CD45RO+ T cells, had a tendency of being more susceptible to RosA-induced apoptosis than that of resting and naïve T-cell subsets. RosA induced the release of cytochrome c from mitochondria and the blockage of mitochondrial depolarization inhibited apoptosis. Taken together, these results suggest that RosA induces apoptosis of activated T-cell subsets from RA patients via a mitochondrial pathway.
Literature
2.
go back to reference VanderBorght A, Geusens P, Raus J, Stinissen P: The autoimmune pathogenesis of rheumatoid arthritis: Role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 31:160–175, 2001PubMedCrossRef VanderBorght A, Geusens P, Raus J, Stinissen P: The autoimmune pathogenesis of rheumatoid arthritis: Role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 31:160–175, 2001PubMedCrossRef
3.
go back to reference Granholm NA, Cavallo T: Autoimmunity, polyclonal B-cell activation and infection. Lupus 1:63–74, 1992PubMed Granholm NA, Cavallo T: Autoimmunity, polyclonal B-cell activation and infection. Lupus 1:63–74, 1992PubMed
4.
go back to reference Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS: HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32:15–21, 1989PubMed Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS: HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32:15–21, 1989PubMed
5.
go back to reference Gumanovskaya ML, Myers LK, Rosloniec EF, Stuart JM, Kang AH: Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells. Immunology 97:466–473, 1999PubMedCrossRef Gumanovskaya ML, Myers LK, Rosloniec EF, Stuart JM, Kang AH: Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells. Immunology 97:466–473, 1999PubMedCrossRef
6.
go back to reference Kadowaki KM, Matsuno H, Tsuji H, Tunru I: CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol 97:212–218, 1994PubMedCrossRef Kadowaki KM, Matsuno H, Tsuji H, Tunru I: CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol 97:212–218, 1994PubMedCrossRef
7.
go back to reference Spargo LD, Cleland LG, Wing SJ, Hawkes JS, Mayrhofer G: Characterization of thoracic duct cells that transfer polyarthritis. Clin Exp Immunol 126:560–569, 2001PubMedCrossRef Spargo LD, Cleland LG, Wing SJ, Hawkes JS, Mayrhofer G: Characterization of thoracic duct cells that transfer polyarthritis. Clin Exp Immunol 126:560–569, 2001PubMedCrossRef
8.
go back to reference Zhang HG, Yang P, Xie J, Liu Z, Liu D, Xiu L, Zhou T, Wang Y, Hsu HC, Mountz JD: Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice. J Immunol 168:4164–4172, 2002PubMed Zhang HG, Yang P, Xie J, Liu Z, Liu D, Xiu L, Zhou T, Wang Y, Hsu HC, Mountz JD: Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice. J Immunol 168:4164–4172, 2002PubMed
9.
go back to reference Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N, Ohta H, Mak TW: CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 162:203–208, 1999PubMed Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N, Ohta H, Mak TW: CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 162:203–208, 1999PubMed
10.
go back to reference Nakashima T, Wada T, Penninger JM: RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol 15:280–287, 2003PubMedCrossRef Nakashima T, Wada T, Penninger JM: RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol 15:280–287, 2003PubMedCrossRef
11.
go back to reference Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY: Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: Cross-talk between T cells and synovial fibroblasts. Arthritis Rheum 50:776–784, 2004PubMedCrossRef Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY: Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: Cross-talk between T cells and synovial fibroblasts. Arthritis Rheum 50:776–784, 2004PubMedCrossRef
12.
go back to reference Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ: Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067, 2005PubMedCrossRef Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ: Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067, 2005PubMedCrossRef
13.
go back to reference Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304–309, 1999PubMedCrossRef Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304–309, 1999PubMedCrossRef
14.
go back to reference Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–970, 1999PubMedCrossRef Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–970, 1999PubMedCrossRef
15.
go back to reference Lubberts E, Van Den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, Van Den Berg WB: IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 170:2655–2662, 2003PubMed Lubberts E, Van Den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, Van Den Berg WB: IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 170:2655–2662, 2003PubMed
16.
go back to reference Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177, 2003PubMed Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177, 2003PubMed
17.
go back to reference Lubberts E, Koenders MI, Oppers-Walgreen B, Van Den Bersselaar L, Coenen-de Roo CJ, Joosten LA, Van Den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659, 2004PubMedCrossRef Lubberts E, Koenders MI, Oppers-Walgreen B, Van Den Bersselaar L, Coenen-de Roo CJ, Joosten LA, Van Den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659, 2004PubMedCrossRef
18.
go back to reference Ogawa Y, Ohtsuki M, Uzuki M, Sawai T, Onozawa Y, Nakayama J, Yonemura A, Kimura T, Matsuno H: Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells. Arthritis Rheum 48:3350–3358, 2003PubMedCrossRef Ogawa Y, Ohtsuki M, Uzuki M, Sawai T, Onozawa Y, Nakayama J, Yonemura A, Kimura T, Matsuno H: Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells. Arthritis Rheum 48:3350–3358, 2003PubMedCrossRef
19.
go back to reference Al-Sereiti MR, Abu-Amer KM, Sen P: Pharmacology of rosmary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37:124–130, 1999PubMed Al-Sereiti MR, Abu-Amer KM, Sen P: Pharmacology of rosmary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37:124–130, 1999PubMed
20.
go back to reference Kelm MA, Nair MG, Strasburg GM, DeWitt DL: Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7:7–13, 2000PubMed Kelm MA, Nair MG, Strasburg GM, DeWitt DL: Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7:7–13, 2000PubMed
21.
go back to reference Choy EH, Kingsley GH, Panayi GS: Monoclonal antibody therapy in rheumatoid arthritis. Br J Rheumatol 37:484–490, 1998PubMedCrossRef Choy EH, Kingsley GH, Panayi GS: Monoclonal antibody therapy in rheumatoid arthritis. Br J Rheumatol 37:484–490, 1998PubMedCrossRef
22.
go back to reference Hur YG, Yun Y, Won J: Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction. J Immunol 172:79–87, 2004PubMed Hur YG, Yun Y, Won J: Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction. J Immunol 172:79–87, 2004PubMed
23.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324, 1998 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324, 1998
24.
go back to reference Acuto O, Michel F: CD28-mediated co-stimulation: A quantitative support for TCR signalling. Nat Rev Immunol 3:939–951, 2003PubMedCrossRef Acuto O, Michel F: CD28-mediated co-stimulation: A quantitative support for TCR signalling. Nat Rev Immunol 3:939–951, 2003PubMedCrossRef
25.
go back to reference Schmidt D, Goronzy JJ, Weyand CM: CD4+ CD7− CD28− T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027–2037, 1996PubMed Schmidt D, Goronzy JJ, Weyand CM: CD4+ CD7− CD28− T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027–2037, 1996PubMed
26.
go back to reference Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E: CD4+CD28− T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109:2744–2748, 2004PubMedCrossRef Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E: CD4+CD28− T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109:2744–2748, 2004PubMedCrossRef
27.
go back to reference Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed
28.
go back to reference Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347–1349, 1995PubMedCrossRef Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347–1349, 1995PubMedCrossRef
29.
go back to reference Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976, 1994PubMedCrossRef Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976, 1994PubMedCrossRef
30.
go back to reference Siegel RM, Chan FK, Chun HJ, Lenardo MJ: The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469–474, 2000PubMedCrossRef Siegel RM, Chan FK, Chun HJ, Lenardo MJ: The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469–474, 2000PubMedCrossRef
31.
go back to reference Hoa TT, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K, Sumida T, Nishioka K: Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 23:1332–1337, 1996PubMed Hoa TT, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K, Sumida T, Nishioka K: Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 23:1332–1337, 1996PubMed
32.
go back to reference Chou CT, Yang JS, Lee MR: Apoptosis in rheumatoid arthritis—Expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 193:110–116, 2001PubMedCrossRef Chou CT, Yang JS, Lee MR: Apoptosis in rheumatoid arthritis—Expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 193:110–116, 2001PubMedCrossRef
33.
go back to reference Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A: JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411:77–82, 1997PubMedCrossRef Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A: JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411:77–82, 1997PubMedCrossRef
34.
go back to reference Soden M, Hassan J, Scott DL, Hanly JG, Moriarty M, Whelan A, Feighery C, Bresnihan B: Lymphoid irradiation in intractable rheumatoid arthritis. Long-term follow-up of patients treated with 750 rads or 2,000 rads. Arthritis Rheum 32:523–530, 1989PubMed Soden M, Hassan J, Scott DL, Hanly JG, Moriarty M, Whelan A, Feighery C, Bresnihan B: Lymphoid irradiation in intractable rheumatoid arthritis. Long-term follow-up of patients treated with 750 rads or 2,000 rads. Arthritis Rheum 32:523–530, 1989PubMed
35.
go back to reference Ueki Y, Nakamura H, Kanamoto Y, Miyazaki M, Yano M, Matsumoto K, Miyake S, Tominaga T, Tominaga M, Yamasaki S, Eguchi K: Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher 5:455–461, 2001PubMedCrossRef Ueki Y, Nakamura H, Kanamoto Y, Miyazaki M, Yano M, Matsumoto K, Miyake S, Tominaga T, Tominaga M, Yamasaki S, Eguchi K: Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher 5:455–461, 2001PubMedCrossRef
36.
go back to reference Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, Kawakami M, Ohsuzu F: Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher 3:178–185, 1999PubMedCrossRef Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, Kawakami M, Ohsuzu F: Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher 3:178–185, 1999PubMedCrossRef
37.
go back to reference Herzog C, Walker C, Muller W, Rieber P, Reiter C, Riethmuller G, Wassmer P, Stockinger H, Madic O, Pichler WJ: Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun 2:627–642, 1989PubMedCrossRef Herzog C, Walker C, Muller W, Rieber P, Reiter C, Riethmuller G, Wassmer P, Stockinger H, Madic O, Pichler WJ: Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun 2:627–642, 1989PubMedCrossRef
38.
go back to reference Kirkham BW, Pitzalis C, Kingsley GH, Chikanza IC, Sabharwal S, Barbatis C, Grahame R, Gibson T, Amlot PL, Panayi GS: Monoclonal antibody treatment in rheumatoid arthritis: The clinical and immunological effects of a CD7 monoclonal antibody. Br J Rheumatol 30:459–463, 1991PubMedCrossRef Kirkham BW, Pitzalis C, Kingsley GH, Chikanza IC, Sabharwal S, Barbatis C, Grahame R, Gibson T, Amlot PL, Panayi GS: Monoclonal antibody treatment in rheumatoid arthritis: The clinical and immunological effects of a CD7 monoclonal antibody. Br J Rheumatol 30:459–463, 1991PubMedCrossRef
39.
go back to reference Keystone E: Treatments no longer in development for rheumatoid arthritis. Ann Rheum Dis 61:43–45, 2002 Keystone E: Treatments no longer in development for rheumatoid arthritis. Ann Rheum Dis 61:43–45, 2002
40.
go back to reference Rep MH, van Oosten BW, Roos MT, Ader HJ, Polman CH, van Lier PA: Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J Clin Invest 99:2225–2231, 1997PubMed Rep MH, van Oosten BW, Roos MT, Ader HJ, Polman CH, van Lier PA: Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J Clin Invest 99:2225–2231, 1997PubMed
41.
go back to reference Ruderman EM, Weinblatt ME, Thurmond LM, Pinkus GS, Gravallese EM: Synovial tissue response to treatment with Campath-1H. Arthritis Rheum 38:254–258, 1995PubMed Ruderman EM, Weinblatt ME, Thurmond LM, Pinkus GS, Gravallese EM: Synovial tissue response to treatment with Campath-1H. Arthritis Rheum 38:254–258, 1995PubMed
42.
go back to reference Liu Z, Xu X, Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD: CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 112:1332–1341, 2003PubMedCrossRef Liu Z, Xu X, Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD: CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 112:1332–1341, 2003PubMedCrossRef
43.
go back to reference Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maar C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593–2603, 1996PubMedCrossRef Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maar C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593–2603, 1996PubMedCrossRef
44.
go back to reference Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352, 1999PubMedCrossRef Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352, 1999PubMedCrossRef
45.
go back to reference Kohem CL, Brezinscheck RI, Wisbey H, Tortorella C, Lipsky PE, Openheimer-Marks N: Enrichment of differentiated CD45Rbdim, CD27-memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 39:844–854, 1996PubMed Kohem CL, Brezinscheck RI, Wisbey H, Tortorella C, Lipsky PE, Openheimer-Marks N: Enrichment of differentiated CD45Rbdim, CD27-memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 39:844–854, 1996PubMed
46.
go back to reference Szodoray P, Jellestad S, Nakken B, Brun JG, Jonsson R: Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Lab Invest 83:1839–1848, 2003PubMedCrossRef Szodoray P, Jellestad S, Nakken B, Brun JG, Jonsson R: Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Lab Invest 83:1839–1848, 2003PubMedCrossRef
47.
go back to reference Goronzy JJ, Weyand CM: T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 16:212–217, 2004PubMedCrossRef Goronzy JJ, Weyand CM: T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 16:212–217, 2004PubMedCrossRef
48.
go back to reference Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ: Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 165:1138–1145, 2000PubMed Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ: Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 165:1138–1145, 2000PubMed
49.
go back to reference Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed
50.
go back to reference Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, Hamann A, Radbruch A, Brauer R: The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7:R291–301, 2005 Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, Hamann A, Radbruch A, Brauer R: The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7:R291–301, 2005
51.
go back to reference van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775–2785, 2004PubMedCrossRef van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775–2785, 2004PubMedCrossRef
52.
go back to reference Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277–285, 2004PubMedCrossRef Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277–285, 2004PubMedCrossRef
53.
go back to reference de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B: CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435–6443, 2004PubMed de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B: CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435–6443, 2004PubMed
54.
go back to reference Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S: Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105:735–741, 2005PubMedCrossRef Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S: Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105:735–741, 2005PubMedCrossRef
55.
go back to reference Goronzy JJ, Weyand CM: Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22:251–255, 2001PubMedCrossRef Goronzy JJ, Weyand CM: Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22:251–255, 2001PubMedCrossRef
56.
go back to reference Wagner UG, Koetz K, Weyand CM, Goronzy JJ: Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 95:14447–14452, 1998PubMedCrossRef Wagner UG, Koetz K, Weyand CM, Goronzy JJ: Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 95:14447–14452, 1998PubMedCrossRef
57.
go back to reference Weyand CM, Goronzy JJ: T-cell responses in rheumatoid arthritis: Systemic abnormalities-local disease. Curr Opin Rheumatol 11:210–217, 1999PubMedCrossRef Weyand CM, Goronzy JJ: T-cell responses in rheumatoid arthritis: Systemic abnormalities-local disease. Curr Opin Rheumatol 11:210–217, 1999PubMedCrossRef
Metadata
Title
Rosmarinic Acid Induces Apoptosis of Activated T Cells from Rheumatoid Arthritis Patients via Mitochondrial Pathway
Authors
YUN-GYOUNG HUR
CHANG-HEE SUH
SUNGJOO KIM
JONGHWA WON
Publication date
01-01-2007
Published in
Journal of Clinical Immunology / Issue 1/2007
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9057-8

Other articles of this Issue 1/2007

Journal of Clinical Immunology 1/2007 Go to the issue